相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
Bobak Bahrami et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2017)
Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab
Mohammed Ashraf et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2017)
Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment
Yuksel Totan et al.
CURRENT EYE RESEARCH (2016)
Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Ehsan Rahimy et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy
Rehan M. Hussain et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2016)
Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option
M. Ashraf et al.
EYE (2016)
The Effectiveness of Intravitreal Ranibizumab in Patients with Diabetic Macular Edema Who Have Failed to Respond to Intravitreal Bevacizumab
Rita Ehrlich et al.
OPHTHALMOLOGICA (2016)
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE
Dante J. Pieramici et al.
OPHTHALMOLOGY (2016)
Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment Outcomes from the Phase 3 Program
Diana V. Do et al.
OPHTHALMOLOGY (2016)
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Analysis From the Diabetic Retinopathy Clinical Research Network Comparative Effectiveness Trial
Eric L. Ross et al.
JAMA OPHTHALMOLOGY (2016)
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema Extrapolation of Data to Clinical Practice
Jeffrey S. Heier et al.
JAMA OPHTHALMOLOGY (2016)
Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness
Chirag P. Shah et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2016)
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
Benjamin J. Thomas et al.
CLINICAL OPHTHALMOLOGY (2016)
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
Michael W. Stewart
WORLD JOURNAL OF DIABETES (2016)
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
John A. Wells et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Influence of Glycosylated Hemoglobin on the Efficacy of Ranibizumab for Diabetic Macular Edema A Post Hoc Analysis of the RIDE/RISE Trials
Alok S. Bansal et al.
OPHTHALMOLOGY (2015)
Short-Term Outcomes of Aflibercept Therapy for Diabetic Macular Edema in Patients With Incomplete Response to Ranibizumab and/or Bevacizumab
Edward H. Wood et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2015)
Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema
Joel Hanhart et al.
CASE REPORTS IN OPHTHALMOLOGY (2015)
Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
Laurence S. Lim et al.
CLINICAL OPHTHALMOLOGY (2015)
Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab
Philipp S. Muether et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2014)
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
C. Ehlken et al.
EYE (2014)
Injection frequency and response to bevacizumab monotherapy for diabetic macular oedema (BOLT Report 5)
Sobha Sivaprasad et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
A Key Role for ROCK in TNF-α-Mediated Diabetic Microvascular Damage
Ryoichi Arita et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Factors Associated With Changes in Visual Acuity and Central Subfield Thickness at 1 Year After Treatment for Diabetic Macular Edema With Ranibizumab
Susan B. Bressler et al.
ARCHIVES OF OPHTHALMOLOGY (2012)
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study) 12-Month Data: Report 2
Michel Michaelides et al.
OPHTHALMOLOGY (2010)
分享论文
